Hepatic Artery Stenosis in Liver Transplant Recipients: Primary Treatment with Percutaneous Transluminal Angioplasty

Untreated HAS carries a high morbidity rate. Hepatic artery PTA can play a large role in the management of HAS by reducing the HAT rate more than threefold. With appropriate lesion selection, hepatic artery PTA will have better patency rates than those associated with hepatic artery stent placement.